T

Trevi Therapeutics, Inc. (TRVI)

NGM – Real Time Price. Currency in USD

15.55

+0.79 (5.36%)

Market open: May 13, 2026, 1:50 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Trevi Therapeutics, Inc. (TRVI)

NGM – Real Time Price. Currency in USD

15.55

+0.79 (5.36%)

Market open: May 13, 2026, 1:50 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

Cost of goods sold

-132K

-147K

-123K

-43K

Gross Profit

-132K

-147K

-123K

-43K

Operating expenses (excl. COGS)

-49M

-51M

-34M

-30M

Operating Income

-49M

-52M

-34M

-30M

Non-operating income, total

7M

4M

5M

719K

Pretax income

-43M

-48M

-29M

Equity in earnings

0

Taxes

64K

30K

32K

72K

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-43M

-48M

-29M

Search stocks

Trevi Therapeutics, Inc. (TRVI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Trevi Therapeutics, Inc. (TRVI)

Income Statement (Annual)